Form 4: Encompass Health COO Plans Future Stock Sale

Encompass Health's EVP and Chief Operating Officer, Patrick William Tuer, reported a planned sale of 2,804 shares of common stock for February 10, 2026.

Summary

• Patrick William Tuer, Executive Vice President and Chief Operating Officer of Encompass Health Corp (EHC), filed a Form 4.
• The filing reports a planned disposition of 2,804 shares of Encompass Health Common Stock.
• The transaction date for this sale is February 10, 2026.
• The shares are planned to be sold at a weighted average price of $107.62 per share, with prices ranging from $107.55 to $107.73.
• Following this planned transaction, Mr. Tuer will beneficially own 16,042 shares of Encompass Health Common Stock.
• The transaction is being made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The planned nature of the sale under a 10b5-1 plan for a future date mitigates concerns typically associated with insider selling, suggesting personal financial management rather than a negative outlook on the company.

Positives

• The transaction is pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to personal financial management rather than an immediate reaction to company performance.

Negatives

• An officer's planned sale of shares, even if pre-arranged, reduces insider ownership and can sometimes be perceived as a lack of confidence, though less so with a 10b5-1 plan.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's operational or financial performance, focusing solely on an insider's planned stock transaction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales by high-level executives, are closely monitored by investors. While a pre-planned sale under a Rule 10b5-1 plan, as indicated here, typically suggests personal financial planning rather than a reaction to immediate company performance, it still represents a reduction in insider holdings. Such plans are common for executives to diversify their portfolios and manage tax liabilities.

Corporate Governance

Stakeholder Impact

• Shareholders: May observe a minor impact on sentiment due to a reduction in insider ownership, though the 10b5-1 plan lessens the negative interpretation.

Key Dates

Recommendation

The planned sale by a key executive, while reducing insider ownership, is being executed under a Rule 10b5-1 plan for a future date. This suggests a pre-determined financial strategy rather than a reaction to current company performance or outlook. Investors should monitor future insider activity but this single, pre-planned transaction does not warrant a change in investment thesis at this time.

Keywords

Encompass Health, EHC, Insider Transaction, Form 4, Stock Sale, Patrick William Tuer, 10b5-1 Plan, Officer Sale